Sec. 204. Reauthorization; reporting requirements
131 words·~1 min read·
/bill/115/hr/2430/pcs/section-204·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 738A(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–1(a) ) is amended— in paragraph (1)— in subparagraph (A)— by striking 2013 and inserting 2018 ; and by striking the Medical Device User Fee Amendments of 2012 and inserting the ; and Medical Device User Fee Amendments of 2017 in subparagraph (B), by striking the Medical Device User Fee Amendments Act of 2012 and inserting the ; and Medical Device User Fee Amendments of 2017 in paragraph (2), by striking 2013 through 2017 and inserting 2018 through 2022 .
Section 738A(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–1(b) ) is amended— in paragraph (1), by striking 2017 and inserting 2022 ; and in paragraph (5), by striking 2017 and inserting 2022 .
Connections2 off-index
2 references not yet in our index
- 21 USC 379j–1(a)
- 21 USC 379j–1(b)
Citation graph
cites case law
Sec. 204
Reauthorization; reporting requirements
Cite21 USC 379j–1(a)
Cite21 USC 379j–1(b)
Cites 2Cited by 0 across 0 sources